Nephrology coverage from early CKD to dialysis.
CKD therapeutics, dialysis-adjacent products, transplant care, and kidney diagnostics.
Nephrology dynamics.
Nephrology has been transformed by value-based kidney care models — DaVita Kidney Care, Strive Health, Somatus, and the Medicare kidney care choices model have shifted the buying motion from individual nephrologists to integrated kidney care platforms. CKD therapeutics (SGLT2s, MRAs, novel agents) have made early-stage CKD a more active sales motion, while dialysis-adjacent products live in a separate world.
Why this specialty fits Solara reps.
Solara nephrology reps carry portfolios that align with the new kidney-care economics — CKD therapeutics alongside diagnostics, with awareness of the value-based kidney care contracting environment. Reps maintain relationships at the integrated-platform level alongside individual nephrologists.
Apply to the networkWhat Solara delivers for nephrology launches.
Manufacturers in nephrology need coverage at the integrated kidney care platforms and at independent nephrology practices. Solara's network covers both, with adoption telemetry tuned to the platform and physician level.
Book a working sessionWhat Nephrology reps see most.
- ·Chronic kidney disease (Stages 3-5)
- ·End-stage renal disease
- ·Diabetic kidney disease
- ·Polycystic kidney disease
- ·Anemia of CKD
- ·CKD-associated mineral and bone disorder
- ·Hyperkalemia
Procedures that anchor the buying motion.
- 90960ESRD-related services, monthly, age 20+, 4+ visits
- 90935Hemodialysis procedure with single physician evaluation
- 50300Cadaveric renal allograft preparation
- 90945Dialysis with single physician evaluation
- 99214Office E/M, established, level 4
Product categories most relevant to nephrology.
Common questions about nephrology on Solara.
- Does Solara cover the integrated kidney care platforms (Strive, Somatus)?
Yes. Integrated kidney care platforms are part of the network coverage, with reps maintaining relationships at the platform-medical-director and clinical-leadership level alongside individual nephrologists.
- Can Solara support CKD therapeutic launches (SGLT2s, MRAs)?
Yes. The novel CKD therapeutic class is one of the most active sales motions in nephrology, and reps are trained on the evidence base, payer dynamics, and the cross-specialty conversations (with cardiology and endocrinology) that drive adoption.
- How does Solara handle the value-based kidney care contracting environment?
Reps are trained on KCC (Kidney Care Choices), VBKC arrangements, and how product adoption fits within the integrated platform contract economics. Manufacturer-specific value dossiers are part of the rep enablement workflow.
- What targeting data is used for nephrology?
Patient volume where reportable, platform affiliation, prescribing patterns for CKD therapeutics, dialysis-clinic relationships, and CKD-stage distribution. ICP scoring surfaces nephrologists and platforms with the right patient mix.
See your nephrology territory.
Drop in your metro on the territory preview tool — we'll surface the top 50 physicians most likely to adopt your product, scored on five signals.